ImmuneSpan was built on one observation: the most powerful wellness data in the world — immune biology, myeloid signaling, epigenetic age — was locked inside academic journals and $10,000 clinics. We built the bridge.
Dr. Stone's career spans two domains that rarely intersect in consumer health: innate immunology and clinical oncology. His research focus on the Myeloid-Adaptive Bridge — the cellular mechanism by which the aging bone marrow shifts from producing adaptive immune cells to myeloid cells — forms the scientific core of ImmuneSpan.
The founding insight came from a frustration shared by thousands of health-conscious Americans: they had access to excellent blood work through standard clinical labs, but no tool that could translate the myeloid signaling data in a standard CBC into actionable wellness intelligence. The NLR was sitting there in every annual blood draw, validated by 5,000 peer-reviewed studies, and most physicians weren't even mentioning it.
"I built the first version of the ImmuneSpan Score for myself — from my own lab results. When I ran it on my own data and compared my Wellness Age to my chronological age, I understood immediately why this needed to be a product."
The V23 engine uses martingale residuals from a Cox Proportional Hazards model — what Dr. Stone describes as "the most scientifically rigorous age-adjustment method available without requiring clinical-grade validation studies." This approach produces age-adjusted population deviation scores that are both mathematically principled and interpretable to a general wellness audience.
The Performance Age has arrived. The Information Age of health — step counts, sleep stages, and "normal" lab ranges — failed to move the needle on chronic disease or biological wellness. Americans have never had more health data and never been more metabolically unwell.
ImmuneSpan was founded to close the Utility Gap between what the science knows and what the consumer can act on. The Myeloid-Adaptive Bridge — the primary driver of immune aging — is fully visible in a standard $40 blood panel. The intelligence required to interpret it has been locked inside academic research. We decoded it. We are handing you the keys.
Our mission is specifically aligned with the MAHA (Make America Healthy Again) movement: we believe that chronic disease is not inevitable, that biological wellness trajectories can be influenced, and that the tools to support healthy aging should not require a concierge medicine membership or a Stanford postdoc. We built ImmuneSpan Business Plan V4 on the premise that an educational wellness platform can be both scientifically rigorous and fully accessible.
Every score, every threshold, every educational recommendation is grounded in peer-reviewed data — not influencer consensus or wellness industry marketing. We cite our sources.
Your biological data is yours. Our Zero-Knowledge architecture means ImmuneSpan employees cannot view your raw blood results. The decryption key lives only in your authenticated session.
We don't sell data access — we sell outcomes. Our Tier 3 Wellness Score Improvement Commitment puts our revenue on the line alongside your biology. Members who complete the full program without improvement receive a full refund of their annual subscription fee.
"Eat more vegetables" is not a protocol. We provide phenotype-specific wellness education: specific compounds, specific patterns, specific contexts — calibrated to your archetype's primary biological signature.
Elite wellness intelligence should not require a $10,000/year concierge clinic. A $29 analysis from a standard annual blood panel should give every American family the same insights that were once reserved for Stanford postdocs.
We built our IS-REG compliance framework (IS-REG-001 through IS-REG-004) before our first customer — establishing formal FDA General Wellness Policy documentation at founding. Every product decision runs through IS-REG-002 before shipping. We don't diagnose disease — we provide a biological education system you own and control.
ImmuneSpan's IS-REG framework was developed before our first customer. Each document establishes a formal boundary between general wellness education and regulated medical device territory. View full compliance documentation →
Establishes ImmuneSpan as a non-device under the FDA General Wellness Policy (January 2019). Documents the intended use statement and low-risk wellness education scope.
Documents every product feature against Class 1 compliance criteria. Each new feature is reviewed before shipping. Prohibits disease-specific claims, physician network APIs, and lab ordering integrations.
Full transparent documentation of the ImmuneSpan Engine V23.0.0 methodology, including the Cox PH martingale residual approach, ~95,000-record training dataset, survey weights, and K-means phenotype clustering.
Formal justification document confirming that each product tier meets the FDA General Wellness Policy intended-use and low-risk criteria. Updated at every major engine version release.
Trust is our most valuable currency. Our SAB provides scientific authority across oncology, immunology, bio-ethics, and the health sovereignty movement.
Expertise in pre-malignant niche detection and inflammatory biomarker panels. Validates our Inflammatory Pattern research framework. Background in Grail/Galleri-adjacent research contexts.
Specialist in HSC myeloid skewing and the biology of the Myeloid-Adaptive Bridge. Reviews our NLR/SIRI/PIV scoring calibration against current published research standards.
Audits our Zero-Knowledge data sovereignty claims and maintains HIPAA/GDPR/APP compliance standards. Ensures the Bio-Sovereignty Shield promise holds up under legal and technical scrutiny.
A prominent voice in the independent health and MAHA movement. Ensures our educational protocols and messaging resonate authentically with the food purity and biological sovereignty demographic.
The 35–55 suburban professional demographic is experiencing something new: they are no longer willing to accept "your labs are normal" as a complete answer. They have watched a generation of parents decline on medications that managed symptoms but never addressed root causes. They are reading the studies, ordering the panels, and making their own decisions about seed oils, processed food, and supplement protocols.
This demographic is not anti-science — they are pro-evidence. They want the data, they can handle the complexity, and they are willing to invest in precision. What they do not have is the immunological expertise to translate a standard CBC into a myeloid wellness profile. That is the exact utility gap ImmuneSpan was built to fill.
We are the bio-informatics layer for the sovereign health consumer — the intelligence platform that sits between your lab report and the educational context that actually helps you understand your biological wellness trajectory.
Your last annual blood draw probably contains everything we need. Enter your NLR and age for a free Wellness Age estimate — no email required.
Get My Free Wellness Score →